He Mengju, Zhang Hui, Zhang Yanfei, Ding Yicen, Zhang Fei, Kang Yani
School of Biomedical Engineering, Bio-ID Center, Shanghai Jiao Tong University, Shanghai, 200240, China.
Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,200030, China.
J Cancer. 2024 Mar 4;15(8):2391-2402. doi: 10.7150/jca.93343. eCollection 2024.
Lung cancer (LC) remains an extremely lethal disease worldwide, and effective prognostic biomarkers are at top priority. With the rapid development of high-throughput sequencing and bioinformatic analysis methods, the quest to characterize cancer transcriptomes continues to move forward. However, the integrated systematic analysis of lncRNA-miRNA-mRNA regulatory network in LC is lacking. In this study, we collected samples of cancer tissues and adjacent normal tissues from patients with lung cancer and conducted transcriptome and small RNA sequencing to identify differentially expressed genes (DEGs), miRNAs (DEMs), and lncRNAs (DELs). The regulatory roles of miRNAs in LC were explained by functional analysis on DEM-targeted genes. The lncRNA-miRNA pairs, miRNA-mRNA pairs, and lncRNA-mRNA pairs were identified and combined to construct the interplay of lncRNA-miRNA-mRNA. We evaluated the prognostic value of selected lncRNA-miRNA-mRNA by Kaplan-Meier analysis. Finally, we analyzed the expression levels of selected DEM, DELs, and DEGs in lung cancer patients and healthy people to verify our findings. A total of 1492 DEGs, 12 DEMs, and 604 DELs were identified in LC patients. Based on the bioinformatic analysis and the regulatory mechanism of ceRNAs, 3 lncRNAs (GATA2-AS1, LINC00632, MIR99AHG), 1 miRNA (hsa-miR-21-5p) and 5 targeted genes (, , , and ) were figured out first. Through further Kaplan-Meier analysis screening the prognostic value, we finally found the hub subnetwork (MIR99AHG-hsa-miR-21-5p-) by collating lncRNA-miRNA pairs, miRNA-mRNA pairs and lncRNA-mRNA pairs. As the key of ceRNA regulatory network, the expression of miRNA-21-5p in lung cancer patients was significantly higher than that in healthy people ( < 0.01), and its high expression was significantly associated with poor prognosis ( = 0.0025). Our study successfully constructed a MIR99AHG-hsa-miR-21-5p- mutually regulatory network, suggesting the potential efficient biomarkers in LC.
肺癌(LC)在全球范围内仍然是一种极其致命的疾病,有效的预后生物标志物是当务之急。随着高通量测序和生物信息分析方法的快速发展,对癌症转录组进行表征的探索不断推进。然而,肺癌中lncRNA-miRNA-mRNA调控网络的综合系统分析尚缺。在本研究中,我们收集了肺癌患者的癌组织和癌旁正常组织样本,进行转录组和小RNA测序,以鉴定差异表达基因(DEGs)、miRNA(DEMs)和lncRNA(DELs)。通过对DEM靶向基因的功能分析来解释miRNA在肺癌中的调控作用。鉴定并组合lncRNA-miRNA对、miRNA-mRNA对和lncRNA-mRNA对,以构建lncRNA-miRNA-mRNA的相互作用。我们通过Kaplan-Meier分析评估所选lncRNA-miRNA-mRNA的预后价值。最后,我们分析了肺癌患者和健康人中所选DEM、DEL和DEG的表达水平,以验证我们的发现。在肺癌患者中总共鉴定出1492个DEG、12个DEM和604个DEL。基于生物信息分析和ceRNAs的调控机制,首先确定了3个lncRNA(GATA2-AS1、LINC00632、MIR99AHG)、1个miRNA(hsa-miR-21-5p)和5个靶向基因(、、、和)。通过进一步的Kaplan-Meier分析筛选预后价值,我们最终通过整理lncRNA-miRNA对、miRNA-mRNA对和lncRNA-mRNA对发现了枢纽子网络(MIR99AHG-hsa-miR-21-5p-)。作为ceRNA调控网络的关键,miRNA-21-5p在肺癌患者中的表达明显高于健康人(<0.01),其高表达与不良预后显著相关(=0.0025)。我们的研究成功构建了MIR99AHG-hsa-miR-21-5p-相互调控网络,提示其在肺癌中具有潜在的有效生物标志物。